Clinical Trial Update: Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area [Phase 3]

View source ↗

Summary

An open-label Phase 3 study evaluating deoxycholic acid for reduction of subcutaneous fat in the submental area completed, with results posted in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fullness

Drugs mentioned

• KYBELLA (deoxycholic acid)

Snippet

Sponsor: Kythera Biopharmaceuticals | Conditions: Moderate or Severe Submental Fullness | Phase 3 | Status: COMPLETED | Results posted: 2016-01-14